Clinical trial · Observational
Eastern Ablation Registry for Solid Tumor (EAST)
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Local tumor ablation is among the major anti-tumor modalities worldwide. Given the number of changes that have taken place in the field of tumor ablation in the past 10 years, it is our intention to ensure that this highly utilized standardization continues to remain relevant as it unites all investigators and clinicians practicing interventional oncology by providing a common language to describe therapies and outcomes, develop studies, and communicate with other medical specialties. In an attempt to attain greater Asian-wide adoption, the investigators will initiate the registry system for local tumor ablation in Taiwan, China, Korea, Singapore, Hong Kong and Thailand.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Solid Tumor Including Thyroid, Bone, Liver, Pancreas | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| RFA, MWA, cryo and IRE | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- To observe the efficacy of local tumor ablation
- timeFrame
- through study completion, an average of 1 year
- description
- Response rate (RR) to local tumor ablation
Secondary outcomes (3)
- measure
- The effect of local tumor ablation
- timeFrame
- up to 3 years
- description
- time-to-progression
- measure
- To observe the survival rate
- timeFrame
- up to 3 years
- description
- overall survival (OS)
- measure
- To observe the progression-free survival rate
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients who meet all inclusion criteria will be included: 1. Males or non-pregnant females, at least 18 years of age (inclusive) 2. Patients with clinically confirmed solid tumor including thyroid, bone, liver, pancreas and those which are scheduated to be treated by local tumor ablation including radiofrequency ablation, microwave ablation, cryoablation and irreversible electroporation 3. Patients who have provided written informed consent 4. Eastern Cooperative Oncology Group (ECOG) Performance Status ≤ 1 5. American Society of Anaesthesiologists (ASA) score ≤ 3 Exclusion Criteria: Patients who meet any exclusion criteria will be excluded: 1. The procedure of local ablation is not completed due to machine or patient problem 2. Received treatment with an investigational agent/ procedure within 30 days prior to local ablation 3. Known history of HIV infection 4. Women who are pregnant 5. Life expectancy is less than 3 months
References
Publications (0)
Data not yet available